换一批Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study.
第一作者：
Alberto S,Pappo
第一单位：
The Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G1X8, Canada. alberto.pappo@sickkids.ca
作者：
医学主题词
青少年(Adolescent);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);儿童(Child);综合疗法(Combined Modality Therapy);多柔比星(Doxorubicin);女(雌)性(Female);粒细胞集落刺激因子(Granulocyte Colony-Stimulating Factor);人类(Humans);异环磷酰胺(Ifosfamide);男(雄)性(Male);美司钠(Mesna);肿瘤辅助疗法(Neoadjuvant Therapy);预防和防护用药(Protective Agents);肉瘤(Sarcoma);软组织肿瘤(Soft Tissue Neoplasms);存活率分析(Survival Analysis);治疗结果(Treatment Outcome);长春新碱(Vincristine)
DOI
10.1200/JCO.2005.03.209
PMID
15767644
发布时间
2024-12-19
- 浏览20
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
